This note about a Cabot Small-Cap Confidential teaser first ran in the Friday File in the Summer of 2013, and the stock is up about 25% since then but is now being pitched as Cabot’s “Stock of the Decade”. What follows was published on June 21, 2013 and has not been updated or revised: *** […]
I’ve got a couple quick personal portfolio updates to share with you today, including an add-on warrant buy, but first I thought you might enjoy a quick look at a teaser ad for one of Thomas Garrity’s picks from Cabot Small-Cap Confidential — they’re promoting this pretty actively right now as a “$20 biotech stock […]
The folks at Cabot are no stranger to promises of doubles and triples — and they especially like to trot out specific pitches like this one, that a health care stock is going from $15 to $45 … and that, of course, makes us quite curious about just what stock they’re talking about. You too? […]
We are apparently in a rut with health and medical teasers this week, and I haven’t the strength to jolt us out of it just yet … plus, I haven’t covered a teaser from the Cabot folks in a while, so let’s have a look at this latest one. The newsletter being promoted is Cabot […]
I’ve been resisting writing about this stock that Cabot is teasing for almost a year for their Small-Cap Confidential newsletter (edited by Thomas Garrity) — I started getting very similar teaser ads from them last July, as best I can tell, and the ad has continued to roll on, with minor variations, almost constantly since […]
Looks for hidden small cap opportunities, claims a “limited circulation” because of generally small and less liquid investments. Formerly edited by Thomas Garrity for many years, Tyler Laundon came to Cabot in 2016 after writing for some Wyatt Research newsletters for several years.
Comments
I subscribe to Thomas Garrity at Cabot Small Cap and I must tell you it has made me a lot of money. I think he has only ...